Introduction {#sec1-1}
============

At present, the use of medicinal plants, owing to their protective properties against diseases such as cancer, cardiovascular and liver diseases, is increasing steadily. Some plant extracts used in conventional medicine are full of compounds with preventive and protective properties, especially on liver diseases.\[[@ref1]\] Black cumin (*Nigella sativa* L.) is a member of ranunculus family with white or light blue flowers that turn black when exposed to air.\[[@ref2]\] The main compounds of the aqueous extract of this plant are thymoquinone, dithymoquinone, thymohydroquinone, and thymol.\[[@ref3]\] Black cumin has antioxidant, anti-inflammatory, and antihistamine properties and strengthens the immune system. It exert numerous pharmacological effects including, reduction of blood sugar, lipid and high blood pressure, excretion of bile and uric acid, protection of kidney, heart, and liver tissues as well as antimicrobial and antiparasitic effects.\[[@ref4]\] Farag *et al*. has shown that thymoquinone advances the liver and kidney changes persuaded by chronic cyclosporine.\[[@ref5]\] A major part of the drugs imported into the body is metabolized by the hepatocytes, and it seems that the liver tissue is damaged during the metabolism of these materials.\[[@ref6]\] Li *et al*. showed a significant correlation between morphine consumption and hepatitis C infection.\[[@ref7]\] Oxidative stress plays a pivotal role in toxic liver damage.\[[@ref8]\] The food and supplement enriched with antioxidant can protect the liver against various oxidative damages of reactive oxygen species (ROS).\[[@ref9]\] Daba and Abdel-Rahman indicated that the black cumin extract can produce antioxidant effects against the liver toxicity induced by carbon tetrachloride.\[[@ref10]\] Increased ROS causes DNA failure, inactivates some proteins, and impairs biologic membranes through induction of oxidative stress.\[[@ref11]\] Crystal morphine is white or light brown and is extracted from opium and is frequently used in medicine as an analgesic drug.\[[@ref12]\] Moreover, morphine induces oxidative stress and apoptosis of neurons, and hepatocyte, glial, and immune system cells.\[[@ref13]\] Bekheet showed that administration of morphine can reduce the size of liver cells, thereby leading to their death.\[[@ref14]\] The cell damage and dysfunction of endocrine and metabolic activities of liver can be recognized, to some extent, by measuring some of the liver enzymes.\[[@ref15]\] Chen reported that morphine consumption increases liver toxicity and damage through increased induction of lipid peroxidation.\[[@ref16]\] Furthermore, Abdel-Wahhab and Aly showed that black cumin can inhibit aflatoxin administration effect on blood and biochemical pathways in the liver of rats.\[[@ref17]\] Given the toxicity effect of morphine, especially inducing oxidative stress and its application as an analgesic drug in medicine as well as thymoquinone properties, especially antioxidative stress, and that no study has evaluated the antioxidative effects of thymoquinone on the morphine-induced liver disorders, the present study was conducted to assess the effects of thymoquinone on the morphine-induced liver disorders in mice.

Methods {#sec1-2}
=======

Laboratory animals {#sec2-1}
------------------

In this study, a total of 48 male BALB/c mice, with a weight range of 27--30 g, were purchased from Razi Institute. The mice were kept at the animal house for 1 week before the commencement of the study under laboratory conditions at 20°C ± 2°C, 12:12 day/night cycle, and free access to food and water. The animals were kept in the standard cages of the animal house of school of medicine; six mice in each cage.\[[@ref18]\]

Experimental protocol {#sec2-2}
---------------------

The mice were divided into eight groups: experimental Group 1: 0.9% normal saline, experimental Group 2: 20 mg/kg morphine, experimental Group 3: 4.5 mg/kg thymoquinone + 20 mg/kg morphine, experimental group 4: 9 mg/kg thymoquinone + 20 mg/kg morphine, experimental group 5: 18 mg/kg thymoquinone + 20 mg/kg morphine, experimental group 6: 4.5 mg/kg thymoquinone, experimental group 7: 9 mg/kg thymoquinone, and experimental group 8: 18 mg/kg thymoquinone. Morphine administered by intraperitoneally injecting as follows: 20 mg/kg once daily within thefirst 5 days and twice per day within the next 5 days. On days 11--20, a dose of up to 30 mg/kg twice per day.\[[@ref19][@ref20]\] Mice with thymoquinone as follows: on days 1--20, thymoquinone once daily, intraperitoneally injecting.\[[@ref21]\] Mice with morphine plus thymoquinone as follows: on days 1--20, thymoquinone once daily plus morphine, intraperitoneally injecting.\[[@ref19][@ref21]\] The same volume of saline was administered.

Chemicals {#sec2-3}
---------

Morphine (C16H19NO3) and thymoquinone (2-isopropyl-5-methylbenzo-1,4-quinone; C10H12O2) were obtained from Sigma Chemical Company (St. Louis, USA) and were dissolved in saline (0.9%) for administration.

Serum blood collection and liver weight measurement {#sec2-4}
---------------------------------------------------

The mice were anesthetized with chloroform and blood samples were taken from the heart. The blood samples were incubated at 37°C to coagulate. The coagulated blood samples were then centrifuged for 15 min at 3000 rpm until the serum was separated. The separated serum was kept at -20°C until the measurement of liver enzymes and nitric oxide (NO).\[[@ref20]\] Animals were killed and sacrificed. Livers were removed and weighed on a microbalance sensitive to 0.001 mg (Precisa 125A, Switzerland) and recorded.

Measurement of liver enzymes {#sec2-5}
----------------------------

The liver was fragmented and turned into a uniform solution. To separate the enzymes, the obtained solution was centrifuged for 20 min twice at 10,000 rpm. The upper part of the solution was separated to measure the enzymes. Alkaline phosphatase (ALP) actions were determined rendering to the procedure described in laboratory applied manual.\[[@ref22]\] Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities were analyzed by the method of Reitman and Frankel.\[[@ref23]\]

Nitric oxide measurement {#sec2-6}
------------------------

NO measurement was carried out indirectly by measuring its stable metabolite, nitrate, using the microplate method. A total of 6 mg zinc sulfate powder was mixed with 400 μl serum sample. The samples were centrifuged for 10 min at 10000 rpm, and supernatant was used for nitrate measurement. Nitrate was converted into nitrite by vanadium chloride recovery (III) method and the nitrite level (μmol/L) of serums was measured by Griess assay.\[[@ref6][@ref24]\]

Tissue preparation {#sec2-7}
------------------

Tissue preparation was performed by an automatic tissue processor machine. Briefly, after fixation (10% formalin at room temperature for 72 h), the tissues were dehydrated with ascending alcohol, they were passed through xylene to clear and finally through paraffin to impregnate and fill the spaces created in the tissues. Fine slices (5 μm) by microtome (Leica RM2125, Germany) and stained with H and E. The preparation was observed under Olympus BX51T32E01 microscope linked to a DP12 Camera with 3.34 million pixel determination and Olysia Bio software (Olympus Optical, Japan).\[[@ref25]\]

Measurement of hepatocytes and central hepatic vein {#sec2-8}
---------------------------------------------------

As a minimum fifty hepatocytes (total 100) from each region were measured in each liver. The entire cellular area was measured for each hepatocyte. Hepatocyte outline was measured after taking a picture with a ×40 objective. To estimate the mean diameter (mean axis), the shortest and longest axis were measured in the drawing of each hepatocyte. Central hepatic vein measurement was performed, using the same methodology.\[[@ref1][@ref6][@ref20]\]

Statistical analysis {#sec2-9}
--------------------

All the quantitative data were presented as mean ± standard deviation. One-way analysis of variance followed by least significant difference *posthoc* test was performed to determine the statistical significance between different groups using SPSS software (Statistical Package for the Social Sciences, version 16.0, SPSS Inc., Chicago, Illinois, USA). The *P* \< 0.05 was considered statistical significant.

Results {#sec1-3}
=======

Liver weight {#sec2-10}
------------

The effective doses of morphine (20 mg/kg (and thymoquinone (4.5, 9, and 18 mg/kg) plus morphine caused a significant decrease in liver weight compared to the saline group (*P* \< 0.05).

Thymoquinone and thymoquinone plus morphine improved liver weight in treated animals of all doses (4.5, 9, and 18 mg/kg) compared with the morphine group (*P* \< 0.05) \[[Figure 1](#F1){ref-type="fig"}\].

![expression experimental groups were equally divided into eight groups. \*Significant decrease of liver weight in morphine group compared to saline group (*P* \< 0.05). \*\*Significant increase in all groups of thymoquinone compared to morphine group (*P* \< 0.05). \*\*\*Significant increase in all groups of thymoquinone plus morphine compared to morphine group (*P* \< 0.05)](IJPVM-9-8-g001){#F1}

Measurement of liver enzymes {#sec2-11}
----------------------------

Morphine caused a significant increase in the mean of ALT, AST, and ALP enzymes compared to saline group (*P* \< 0.05). In addition, the mean of ALT, AST, and ALP enzymes decreased significantly in thymoquinone and thymoquinone plus morphine (4.5, 9, and 18 mg/kg) administration compared to morphine group (*P* \< 0.05) \[[Table 1](#T1){ref-type="table"}\].

###### 

Effect of morphine, thymoquinone, and thymoquinone plus morphine administration on liver enzymes and the mean nitric oxide levels of expression experimental groups

![](IJPVM-9-8-g002)

Nitric oxide measurement {#sec2-12}
------------------------

The mean level of NO in blood serum increased significantly in the morphine (20 mg/kg) and thymoquinone plus morphine (4.5, 9, and 18 mg/kg) groups compared to the saline group (*P* \< 0.05). Furthermore, the mean of NO in blood serum decreased significantly in thymoquinone (4.5, 9, and 18 mg/kg) and thymoquinone (4.5, 9, and 18 mg/kg) plus morphine compared to morphine group (*P* \< 0.05) \[[Table 1](#T1){ref-type="table"}\].

Measurement of hepatocytes and central hepatic vein {#sec2-13}
---------------------------------------------------

The mean diameter of hepatocytes and central hepatic vein were significantly increased in morphine group in comparison with saline group (*P* \< 0.05).

Furthermore, thymoquinone (4.5, 9, and 18 mg/kg) and thymoquinone (4.5, 9, and 18 mg/kg) plus morphine caused a significant decrease in the mean diameter of hepatocytes and central hepatic vein comparison with morphine group administration (*P* \< 0.05) \[[Figure 2](#F2){ref-type="fig"}\].

![Effect of morphine, thymoquinone, and thymoquinone plus morphine administration on the mean of hepatocytes and central hepatic vein diameter of expression experimental groups. \*Significant increase of the mean hepatocytes and central hepatic vein diameters in morphine groups compared to saline groups (*P* \< 0.05). \*\*Significant decrease in all groups of thymoquinone administration compared to morphine groups (*P* \< 0.05). \*\*\*Significant decrease in all groups of thymoquinone plus morphine administration compared to morphine groups (*P* \< 0.05)](IJPVM-9-8-g003){#F2}

Histopathological observations {#sec2-14}
------------------------------

At 20 days of treatment with morphine (examination of H and E sections), the liver section seemed with variable variations and noticeable injury. These modifications were showed by more distributed Kupffer cells around central vein and enlargement of central hepatic vein compared to saline stage. Treatment with morphine plus thymoquinone (18 mg/kg) showed thymoquinone reduced liver injury due to morphine toxicity and largely suppressed lymphocytic infiltration \[[Figure 3](#F3){ref-type="fig"}\].

![Histological changes of liver H and E staining (magnification, ×100). (a) micrograph of liver section of mice in saline group showing a normal liver structure, (b) micrograph of liver section treated with thymoquinone (18 mg/kg) showing a normal liver structure, (c) micrograph of liver section treated with morphine showing more distributed Kupffer cells around central vein (thin arrows) and enlargement of central hepatic vein (thick arrow), and (d) micrograph of liver section treated with morphine plus thymoquinone (18 mg/kg) showing a normal liver structure](IJPVM-9-8-g004){#F3}

Discussion {#sec1-4}
==========

Liver is one of the vital body organs that play a major role in detoxification of the toxic elements, environmental pollutants, and chemical drugs. However, oxidative stress is a factor that greatly cause liver failure caused by drugs and toxins.\[[@ref22]\] The increased activity of liver enzymes performance indices, AST, ALT, and ALP, in serum is indicative of liver damage, which leads to reduced performance of liver cells.\[[@ref6]\] Therefore, in the present study, the increased serum level of these enzymes in the groups receiving morphine can be indicative of the incidence of damage to the liver cells. Morphine can be metabolized into free radicals. Furthermore, lipid peroxidation is observed in the people using heroin.\[[@ref15]\] In the current research, treatment with thymoquinone significantly inhibited the elevation of serum liver enzymes. The compounds in black cumin such as thymoquinone have a scavenger effect against free radicals.\[[@ref26]\] On the other hand, thymoquinone is an inhibitor of lipid peroxidation *in vitro*. Thymoquinone, as an active ingredient of *N. sativa*, protects the liver against the toxicity induced by tert-butyl hydroperoxide by inhibiting glutathione reduction and decreasing the serum level of enzymes such as ALT and AST in the hepatocytes of mice.\[[@ref27]\] The study of Nili-Ahmadabadi *et al*. showed that thymoquinone reduces the serum level of liver enzymes such as ALT, AST, and ALP, which is in line with the results of the present study.\[[@ref21]\] In the current study, changes were observed in the liver tissue in the groups receiving morphine, as hyperemia of the sinusoids, accumulation of macrophages around the central veins, and infiltration of lymphoid cells in the port space. The increased activity of opioid system can induce liver damage.\[[@ref28]\] It seems that macrophages are activated in response to tissue damage and release toxic mediators such as tumor necrosis factor-alpha, interleukin-1, and nitric acid. The liver macrophages are the same kupffer cells that exist in liver sinusoids. Studies have shown that accumulation of these cells and secretion of toxic mediators in the nonnecrotic areas are involved in induction of liver toxicity and cause liver necrosis.\[[@ref29]\] Due to simultaneous administration of thymoquinone and morphine, only poor degenerative changes were observed and no trace of necrosis was found, which can show the protective effects of thymoquinone extract against morphine toxicity. It seems that these beneficial effects of *N. sativa* are associated with the antioxidant properties and reducing oxidative stress of the compounds existing in thymoquinone.\[[@ref30]\] The results of the study of Salahshoor *et al*. indicated that administration of kerosene, as an antioxidant, reduces the inflammatory effects of morphine on the liver, which is in agreement with the findings of the current study.\[[@ref20]\] The results of the analysis of liver weight among the studied groups demonstrated a significant reduction in the liver weight between the saline group and morphine groups, indicating that the effects of morphine on the reduction of liver weight were eliminated to a large extent after treatment with thymoquinone. It seems that morphine administration reduces liver weight through impairing the liver cells and disturbing the real metabolism of the mice.\[[@ref6]\] The study carried out by Sumathi *et al*. showed that subcutaneous injection of morphine reduced the body weight, which is parallel with the results of the present research.\[[@ref31]\] Increased liver weight can be indicative of the improved nutrition of the animals under treatment with thymoquinone. This weight increase can be due to the effects of thymoquinone on the enhanced diet of the studied animals.\[[@ref32]\] The results of this study also showed a significant increase in the mean diameter of hepatocytes and central hepatic vein between saline and morphine groups, and thymoquinone administration reduced the mean diameter of hepatocytes and central hepatic vein in all groups compared to the morphine group. It seems that morphine has hepatotoxic properties, due to increased glutathione, and causes the loss of liver cytoplasmic cells.\[[@ref33]\] Changing in the size of liver\'s central vein and hepatic cells could be the consequence of the elevation in the metabolic activity of cells to excrete toxin from the body during detoxification process.\[[@ref34]\] Morphine metabolism induced free radicals then it caused lipid peroxidation, reaction with DNA and membrane proteins, and consequently cell damage through various mechanisms.\[[@ref35]\] Thymoquinone as antioxidant compound may exert inhibitory effect on cytochrome P450, prevent further morphine metabolism and reduce the production of free radicals, consequently.\[[@ref36]\] The findings of the present study are similar to the study carried out by Salahshoor *et al*., in which they showed curcumin administration resulted in the increasing diameter of hepatocytes.\[[@ref6]\] Moreover, the findings indicated that morphine could significantly increase NO level in blood serum; however, NO was significantly reduced in thymoquinone groups. These results may confirm the antioxidant and anti-inflammatory effects of thymoquinone. NO is a free radical that is produced in the mammalian cells, it is involved in the regulation of physiologic processes and its increased production is followed by induction of various diseases.\[[@ref20][@ref37]\] Morphine can increase the production of NO through intracellular regulation of calcium and activation of calcium/calmodulin-dependent NO synthesis. Morphine can also increase NO production directly through naloxone-sensitive receptors.\[[@ref38]\] On the other hand, the hydroxyl radicals generated by NO and superoxide anion interfere with the pathogenesis process and liver toxicity.\[[@ref39]\] Owing to the ability of antioxidants in removal of free radicals, these substances can destroy and impair NO system (protein enzymes, substrates, and cofactors) and consequently reduce NO production.\[[@ref40]\] Thymoquinone through induction of oxidative stress, inhibit the increased production of NO.\[[@ref41]\] Owing to the ability of antioxidants in removal of free radicals, these substances can destroy and impair nitric oxide system (protein enzymes, substrates and cofactors) and consequently reduce nitric oxide production.\[[@ref42]\] Thymoquinone through induction of oxidative stress, inhibit the increased production of nitric oxide.\[[@ref43]\] The results of the current study confirm the findings of Salahshoor *et al*. indicating that nicotine could increase serum NO and curcumin, as an antioxidant, was able to prevent the elevation of blood serum NO in the laboratory animals.\[[@ref6]\]

Conclusions {#sec1-5}
===========

The findings of this study showed that administration of thymoquinone, as a potent antioxidant, could have protective properties against the destructive effects of morphine in the liver of mice. In addition, the effects of thymoquinone on the liver enzymes and NO level were observed, which indicated thymoquinone could have protective effects against the free radicals produced by morphine and could consequently improve the performance and structure of liver.
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